Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Haleon plc HLN NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • GB • USD

SharesGrow Score
63/100
4/7 Pass
SharesGrow Intrinsic Value
$16.99
+75.2%
Analyst Price Target
$10.20
+5.2%

HLN Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for HLN.

People Also View

BDX
BDX
Becton, Dickinson and Company
$155.73
+0.19%
 TAK
TAK
Takeda Pharmaceutical Company Limited
$17.85
+0.17%
 ZTS
ZTS
Zoetis Inc.
$121.11
+0.86%
 CAH
CAH
Cardinal Health, Inc.
$214.95
+0.36%
 ALC
ALC
Alcon Inc.
$79.94
+0.25%
 TEVA
TEVA
Teva Pharmaceutical Industries Limited
$31.77
+1.99%
 A
A
Agilent Technologies, Inc.
$120.40
+2.47%
 RMD
RMD
ResMed Inc.
$230.69
+0.19%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message